Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature.
about
Oligometastasis and oligo-recurrence: more than a mirageRole of radiotherapy in metastatic non-small cell lung cancerStereotactic radiotherapy for early lung cancer: Evidence-based approach and future directionsPrognostic impact of M descriptors of the 8th edition of TNM classification of lung cancer.Radical irradiation of extracranial oligometastases.Impact of metformin use on survival in locally-advanced, inoperable non-small cell lung cancer treated with definitive chemoradiation.Predictors for long-term survival free from whole brain radiation therapy in patients treated with radiosurgery for limited brain metastasesComplete Disappearance of Choroidal Metastasis from Lung Adenocarcinoma Treated with Bevacizumab and Chemotherapy.The biology and treatment of oligometastatic cancer.Outcome and prognostic factors of multimodal therapy for pulmonary large-cell neuroendocrine carcinomas.Aggressive therapy for patients with non-small cell lung carcinoma and synchronous brain-only oligometastatic disease is associated with long-term survival.Might radiation therapy in addition to chemotherapy improve overall survival of patients with non-oligometastatic Stage IV non-small cell lung cancer?: Secondary analysis of two prospective studiesRadiotherapy Combined With Androgen Deprivation for Bone Oligometastases After Primary Curative Radiotherapy for Prostate Cancer: A Retrospective StudyUnexpected long survival of brain oligometastatic non-small cell lung cancer (NSCLC) treated with multimodal treatment: a single-center experience and review of the literatureSurgical treatment in non-small cell lung cancer with pulmonary oligometastasisOligometastatic non-small-cell lung cancer: current treatment strategies.Should aggressive thoracic therapy be performed in patients with synchronous oligometastatic non-small cell lung cancer? A meta-analysisTowards a molecular basis of oligometastatic disease: potential role of micro-RNAs.Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium.Radiation therapy for oligometastatic non-small cell lung cancer.Integration of Stereotactic Body Radiation Therapy With Tyrosine Kinase Inhibitors in Stage IV Oncogene-Driven Lung CancerThe development of stereotactic body radiotherapy in the past decade: a global perspective.Primary Metastatic Synovial Sarcoma: Experience of the CWS Study Group.A pooled analysis of stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small cell lung cancer: is failure to recruit patients into randomized trials also an answer to the research question?Thoracic radiotherapy (TRT) improved survival in both oligo- and polymetastatic extensive stage small cell lung cancer.Postoperative oligo-recurrence of non-small-cell lung cancer: clinical features and survival†.Is there a benefit to locally consolidative therapy for oligometastatic non-small cell lung cancer?How aggressive one need to be in treatment of patients with oligometastasis from non-small cell lung cancer?Radical local therapy in combination with standard treatment for oligometastatic stage IV non-small-cell lung cancer.Oligometastatic non-small cell lung cancer: a significant entity outside of specialized cancer centers?The oligometastatic state - separating truth from wishful thinking.Feasibility of tissue re-biopsy in non-small cell lung cancers resistant to previous epidermal growth factor receptor tyrosine kinase inhibitor therapies.Phase II study of stereotactic body radiotherapy to primary tumor and metastatic locations in oligometastatic nonsmall-cell lung cancer patients.Multimodality Treatment of Advanced Non-small Cell Lung Cancer: Where are we with the Evidence?Surgical approach in the oligometastatic patient.Consolidative ablative radiotherapy improves outcomes in oligometastatic non-small cell lung cancer: a further step toward new evidence.Surgical approaches in patients with oligometastatic non-small cell lung cancer.Long-term survival without surgery in NSCLC patients with synchronous brain oligometastasis: systemic chemotherapy revisited.Suppression of a cancer stem-like phenotype mediated by alpha-lipoic acid in human lung cancer cells through down-regulation of β-catenin and Oct-4.The current state of oligometastatic and oligoprogressive non-small cell lung cancer
P2860
Q26828767-4E39EBC7-66DF-4548-B146-89C6FCCC3513Q27010575-E3EAB3CA-B11D-4ABC-9EB2-814A955A27A2Q28085744-9B8200D2-8D78-4885-9CD5-26F9C4C5A67AQ33571340-B73BDE40-131E-4CF0-BAF7-CD4B2A7AA625Q34124296-CE14F353-9055-42D9-A75A-4A75E29A2DA9Q35290403-CDC705DF-CC14-4322-A4A0-974FB72F1FF9Q35591189-2639F9A7-DE98-4567-A633-385D28BCC80EQ35630590-78D04DC8-303C-4D3F-91F3-75DA8A1FDDD8Q35832153-4EAB71E4-5751-430D-9899-AD060B0F4B7BQ35954065-88FED65E-EDB2-4316-9C1D-52F80A77A198Q36116869-BE13F940-8DC6-49A0-9DD2-8C6C9704E1ACQ36200218-72A65D0B-0639-460D-A500-92FA33CA3D37Q36581142-699D65A2-E81B-4D19-A7B1-6C40A7F17CDBQ37584420-9229C2AA-9242-4B9F-9760-0441DA031968Q37620819-130420C9-BDE0-409E-8F5E-667781EE456BQ37643566-87600CE8-3EE5-4487-927C-B52D5D808BF5Q37677637-35CD2A15-0858-47DF-8A56-677BB50B2B86Q38223512-D55ACD8F-2C30-4B42-B476-6BD890865ABDQ38263008-6D32A068-C5C6-4039-9E46-7C334BF8D366Q38463103-DDC409DB-A495-4A4B-A2F1-9EACE09B8B9CQ38880324-731A1A05-6362-448B-85D5-C107F819C73BQ38967475-45D6716B-BD23-45E5-BAD1-F4B73A1449CCQ39898636-7CC2917B-1106-42E5-BD29-CD02CD1D7A8EQ41112332-44DE3743-6E32-4AD2-8EEF-AA11C7CC56DEQ41504138-BB4CE8D4-2DE8-4A1F-B812-A1471F3D2B45Q41557929-5B53B611-7F3C-4E9F-8B71-A544A5D6DB82Q42314906-3E88095E-18BB-405B-AA7F-15F2CA9F51E1Q42354906-6C5E8FBE-0C84-40AB-871B-1706A8001083Q42359755-6A0E9C54-CDBD-4AD3-99CC-0416694C2328Q42759242-D0CCA129-1AEA-4576-AC86-0D7F73E03DBBQ46288612-CC313AA1-F784-4B52-852C-66E5814171C8Q47103202-9C83D15B-49CF-46E1-8D67-F4BFDFF2B143Q48609781-A4C54B1B-1BFE-409D-BFF4-B38211CC4150Q49773079-E2CD7540-815D-40C4-BC90-1CBBB20FCB16Q52581734-956B1B71-56CD-47F4-B754-86256240BD5FQ52614507-171B4C9E-E8A0-4FF1-9C15-6C1493F9ADBDQ52620288-A4A8DE0E-9BA5-4E5A-A404-8A88D37A0DD3Q52715757-E7BADA8A-75C0-4E7E-9DC4-237E96375B2EQ53544699-69C3A436-FDB0-4D67-BA53-1977D902579CQ57172942-1C458E25-2406-4E38-BE57-5D0A7F896DA1
P2860
Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Is there an oligometastatic st ...... atic review of the literature.
@en
type
label
Is there an oligometastatic st ...... atic review of the literature.
@en
prefLabel
Is there an oligometastatic st ...... atic review of the literature.
@en
P2093
P1433
P1476
Is there an oligometastatic st ...... atic review of the literature.
@en
P2093
Allison Ashworth
David Palma
Gabriel Boldt
George Rodrigues
P304
P356
10.1016/J.LUNGCAN.2013.07.026
P577
2013-08-20T00:00:00Z